ZIRGAN (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the ZIRGAN drug offered from Bausch & Lomb Incorporated. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
| NON-PROPRIETARY NAME: | ganciclovir |
| SUBSTANCE NAME: | GANCICLOVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-04-30 |
| END MARKETING DATE: | 0000-00-00 |
ZIRGAN HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZIRGAN from Bausch & Lomb Incorporated |
| LABELER NAME: | Bausch & Lomb Incorporated |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.5(mg/g) |
| START MARKETING DATE: | 2010-04-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 24208-535_adf5012d-1077-42c8-ab9d-49ff64abf4a2 |
| PRODUCT NDC: | 24208-535 |
| APPLICATION NUMBER: | NDA022211 |
Other GANCICLOVIR Pharmaceutical Manufacturers / Labelers:
